대리모 출산 시장 보고서 : 종류별, 기술별, 서비스 제공자별, 지역별(2026-2034년)

The global surrogacy market size reached USD 204.6 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 329.2 Million by 2034, exhibiting a growth rate (CAGR) of 5.43% during 2026-2034. The rapid growth of fertility tourism, increasing prevalence of infertility, the availability of convenient and inexpensive surrogacy, and the implementation of favourable payment policies by the governing authorities of many countries represent some of the key factors driving the growth of the market.

Surrogacy Market Trends/Drivers:

Legal Framework and Support

The legal environment significantly affects the market for surrogacy. The jurisdiction with clear and supportive legislations eliminates the unnecessary risks associated with surrogacy for all the parties involved and creates a safe and trusted process which also suits the surrogates. For instance, gestational surrogacy accounts for approximately 90% of all surrogacy arrangements. The success rate for gestational surrogacy is around 75%. Such legal support guarantees the rights protection and defines parental custodies thus appealing to a wider intended parents demographic.

Advancements in Reproductive Technologies

The innovations that were made in the area of reproductive medicine have made surrogacy safer and more efficient. The probability and success rate of pregnancy are increased by innovations such as IVF, genetic screening, and embryo transfer techniques, hence making surrogacy attractive to those who wish to start or grow their families. For instance, the pregnancy success rate per embryo transfer in gestational surrogacy ranges from 30% to 60%. The success rates may be higher when using younger and healthy surrogates. Approximately 2% of babies born in the United States were conceived using assisted reproductive technology. Success rates vary but are closely correlated with the quality of the eggs and embryos. PGT- tested embryos have a live birth rate of 75-80%.

Societal Acceptance and Changing Norms

The growth of the surrogacy market is driven by the growing societal acceptance of different family forms, including those formed through surrogacy. With the reduction of cultural and social barriers, surrogacy is becoming a more acceptable option in modern society. For instance, a study found that 54.8% of medical students and 52.9% of lawyers surveyed in Lebanon were supportive of surrogacy. Such shift is based on the increasing level of awareness and understanding in surrogacy practices.

Surrogacy Industry Segmentation:

Breakup by Type:

• Gestational Surrogacy
• Traditional Surrogacy

Gestational surrogacy dominates the market

Gestational surrogacy method involves the surrogate carrying the pregnancy that is conceived from the eggs and sperm of the intended parents or donors. It offers unique benefits, such as reducing the genetic connection between the surrogate and the offspring, thus solving legal and psychological challenges. Gestational surrogacy also provides an opportunity for individuals and couples with reproductive issues, same-sex couples, and people interested in genetic diversity. Additionally, the improvements in accuracy of assisted reproductive technologies, namely in vitro fertilization (IVF), are driving up the success rates of gestational surrogacy.

Breakup by Technology:

• IVF with ICSI
• IVF without ICSI
• Intrauterine Insemination

IVF with ICSI holds the largest share in the market

In vitro fertilization (IVF) with intracytoplasmic sperm injection (ICSI) is a sophisticated approach to assisted reproductive technology that overcomes male infertility issues by injection of a single sperm directly into an egg, resulting in maximized fertilization. IVF combined with ICSI allows intended parents to deal with the complicated fertility problems, so surrogacy services become available to more clients. Additionally, the high success rates linked with this procedure also lead intended parents to regard surrogacy as a reliable avenue to happiness and as such, these success rates only make the demand for surrogacy services to thrive. The interconnection of IVF with ICSI increases the medical applicability of surrogacy and adds forces to its reputation as an efficacious instrument in the market development.

Breakup by Service Provider:

• Hospitals
• Fertility Clinics
• Others

Fertility Clinics represent the most popular service provider

Fertility clinics are a key driver in stimulating the market growth by providing necessary medical knowledge and facilities. These clinics provide a variety of advanced reproductive technologies, including in vitro fertilization (IVF) and embryo transfer procedures, which are basic methods for surrogacy. The fertility clinics offer full medical assessments, detailed treatment plans, and constant surveillance over the whole surrogacy process, thereby providing the very best results. Moreover, fertility clinics work closely with surrogacy agencies and legal experts, thus, providing a smooth process for intended parents and surrogates. Fertility clinics facilitate the market growth as they are the centers of medical innovation and support that make the successful pregnancies possible, facilitate family expansion, and nurture intended parents and surrogates' partnerships.

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

North America exhibits a clear dominance in the market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

The lead in the surrogate market was taken by North America because of its good legal, medical, and social environment. The robust regulations in the region in countries, such as the United States and Canada, ensure the safety of intended parents and surrogates. The advanced medical facilities and the competence of the medical personnel in the field of assisted reproductive technologies, in combination with a tolerant social setting in North America, attract both domestic and international individuals and couples desiring surrogacy services. Furthermore, the multi-ethnic population of the region and changes in the perception of the family have promoted surrogacy.

Competitive Landscape:

Major surrogacy agencies are adopting the digital age and improving the communication between intended parents, surrogates, and medical professionals. They are incorporating new techniques in advanced embryo screening, this will improve the success rates and reduce the chances of genetic disorders. Some significant players are experimenting with eco-friendly approaches through implementing sustainability in fertility treatment. There are more associations with fertility clinics and legal professionals who aid in following changing regulations. All these innovations together represent the assertion of key players to provide progress as to the surrogacy experience in technology and medicine.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

• Bourn Hall Fertility Clinic
• Care Fertility
• Circle Surrogacy
• Extraordinary Conceptions
• Growing Generations
• Houston Fertility Center
• IVIRMA Global
• Kindbody
• Max Healthcare
• New Hope Fertility Clinic
• Nova IVF
• Ovation Fertility

Key Questions Answered in This Report

• 1.What was the size of the global surrogacy market in 2025?
• 2.What is the expected growth rate of the global surrogacy market during 2026-2034?
• 3.What are the key factors driving the global surrogacy market?
• 4.What has been the impact of COVID-19 on the global surrogacy market?
• 5.What is the breakup of the global surrogacy market based on the type?
• 6.What is the breakup of the global surrogacy market based on the technology?
• 7.What is the breakup of the global surrogacy market based on the service provider?
• 8.What are the key regions in the global surrogacy market?
• 9.Who are the key players/companies in the global surrogacy market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Surrogacy Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Type

• 6.1 Gestational Surrogacy
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Traditional Surrogacy
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Technology

• 7.1 IVF with ICSI
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 IVF without ICSI
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Intrauterine Insemination
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by Service Provider

• 8.1 Hospitals
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Fertility Clinics
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Others
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Bourn Hall Fertility Clinic
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
  • 14.3.2 Care Fertility
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
  • 14.3.3 Circle Surrogacy
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
  • 14.3.4 Extraordinary Conceptions
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
  • 14.3.5 Growing Generations
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
  • 14.3.6 Houston Fertility Center
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
  • 14.3.7 IVIRMA Global
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
  • 14.3.8 Kindbody
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 Financials
    • 14.3.8.4 SWOT Analysis
  • 14.3.9 Max Healthcare
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
    • 14.3.9.3 Financials
  • 14.3.10 New Hope Fertility Clinic
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
  • 14.3.11 Nova IVF
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
  • 14.3.12 Ovation Fertility
    • 14.3.12.1 Company Overview
    • 14.3.12.2 Product Portfolio